摘要
系统回顾对原发性高级别脑胶质瘤患者进行的标准治疗，并讨论有效的新的治疗方法。手术、放疗、化疗是治疗高级别胶质瘤的主要方法，分子标记是补充临床预后因素某些情况下能够指导治疗决策。快速发展的技术可使用分子数据提高我们对这种疾病发病机制和增殖的认识。有效地验证预后生物标志物和识别肿瘤，可提高疗效。
Objective Systematically reviewed the standard treatment of primary brain glioma patients high levels,and discussed effective new therapies. Surgery,radiotherapy and chemotherapy are the main methods of treatment of high？grade gliomas, molecular markers supplement clinical prognostic factors under certain circumstances be able to guide treatment decisions. The rapid development of technology using molecular data can improve our understanding of the disease pathogenesis and proliferation. Effectively validate prognostic biomarkers and identification of tumor may improve the outcome.
出处
《中国综合临床》
2016年第7期670-672,共3页
Clinical Medicine of China
关键词
脑胶质瘤
诊断
预后因素
治疗
Glioma
Diagnosis
Prognostic factors
Treatment
